Published in J Immunol on April 01, 1997
Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes. Mol Biol Cell (1999) 2.80
Death, autoantigen modifications, and tolerance. Arthritis Res (2000) 1.75
Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest (2001) 1.40
Mercury exposure, malaria, and serum antinuclear/antinucleolar antibodies in Amazon populations in Brazil: a cross-sectional study. Environ Health (2004) 1.38
Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics (2006) 1.32
Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect (1999) 1.26
Mercury-induced autoimmunity in mice. Environ Health Perspect (2002) 1.12
Toxicology of autoimmune diseases. Chem Res Toxicol (2010) 1.05
Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect (2003) 1.05
Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved. Immunology (1999) 1.04
Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect (1999) 1.04
Serum autoantibody profiling using a natural glycoprotein microarray for the prognosis of early melanoma. J Proteome Res (2010) 0.97
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology (2013) 0.96
Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the United States: NHANES. Environ Health Perspect (2015) 0.94
Metals and kidney autoimmunity. Environ Health Perspect (1999) 0.93
Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response. Clin Exp Immunol (2003) 0.93
Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease. Int J Mol Sci (2014) 0.91
Murine metal-induced systemic autoimmunity: baseline and stimulated cytokine mRNA expression in genetically susceptible and resistant strains. Clin Exp Immunol (2001) 0.89
Environmentally induced autoimmune diseases: potential mechanisms. Environ Health Perspect (1999) 0.89
Exposure to inorganic mercury in vivo attenuates extrinsic apoptotic signaling in Staphylococcal aureus enterotoxin B stimulated T-cells. Toxicol Appl Pharmacol (2007) 0.86
Gold- and silver-induced murine autoimmunity--requirement for cytokines and CD28 in murine heavy metal-induced autoimmunity. Clin Exp Immunol (2008) 0.85
Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox Res (2009) 0.84
Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity. Environ Health Perspect (1999) 0.84
Non-canonical Cajal bodies form in the nucleus of late stage avian oocytes lacking functional nucleolus. Histochem Cell Biol (2012) 0.81
Cytological maps of lampbrush chromosomes of European water frogs (Pelophylax esculentus complex) from the Eastern Ukraine. BMC Genet (2013) 0.80
Induction of autoimmunity to brain antigens by developmental mercury exposure. Toxicol Sci (2010) 0.80
Centromeric protein bodies on avian lampbrush chromosomes contain a protein detectable with an antibody against DNA topoisomerase II. Chromosoma (2004) 0.79
β2-microglobulin is required for the full expression of xenobiotic-induced systemic autoimmunity. J Immunotoxicol (2011) 0.79
Coexposure to mercury increases immunotoxicity of trichloroethylene. Toxicol Sci (2010) 0.79
Elevated levels of antibodies against xenobiotics in a subgroup of healthy subjects. J Appl Toxicol (2014) 0.78
The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line. Cancer Biomark (2010) 0.78
Gold causes genetically determined autoimmune and immunostimulatory responses in mice. Clin Exp Immunol (2007) 0.77
Mercury alters endogenous phosphorylation profiles of SYK in murine B cells. BMC Immunol (2017) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases. Arthritis Rheum (1979) 13.72
Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med (1972) 11.51
Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol (1982) 9.73
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest (1966) 8.64
Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol (1966) 7.40
Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A (1980) 7.33
Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol (1999) 6.24
Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science (1968) 5.88
Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum (1976) 5.33
Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med (1975) 5.00
Crystal structure of a TFIIB-TBP-TATA-element ternary complex. Nature (1995) 4.93
Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest (1975) 4.62
Autoantibody to a nuclear antigen in proliferating cells. J Immunol (1978) 4.36
Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome. Arthritis Rheum (1976) 4.02
Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J Exp Med (1991) 4.02
Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum (1980) 3.87
Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine. J Biol Chem (1985) 3.60
Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med (1978) 3.58
Immunological and ultrastructural studies of the nuclear coiled body with autoimmune antibodies. Exp Cell Res (1991) 3.44
Monoclonal autoantibody from a (New Zealand black x New Zealand white)F1 mouse and some human scleroderma sera target an Mr 34,000 nucleolar protein of the U3 RNP particle. Arthritis Rheum (1987) 3.09
Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem (1979) 2.99
A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med (1988) 2.98
A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med (1981) 2.82
Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res (1986) 2.74
Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus. J Lab Clin Med (1967) 2.71
Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum (1995) 2.67
Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med (1978) 2.52
Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. J Lab Clin Med (1970) 2.41
A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med (1999) 2.36
Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol (1982) 2.29
Antinucleolar antibodies in human sera. J Immunol (1973) 2.28
Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest (1991) 2.28
Association between the nucleolus and the coiled body. J Struct Biol (1991) 2.18
Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res (1987) 2.13
Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc Natl Acad Sci U S A (1993) 2.13
Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. J Exp Med (1980) 2.10
An immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis Rheum (1966) 2.07
Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods (1988) 2.07
Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J Neurosci (1997) 2.01
Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest (1987) 1.99
An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. J Clin Invest (1967) 1.99
Detection of a nucleolar 7-2 ribonucleoprotein and a cytoplasmic 8-2 ribonucleoprotein with autoantibodies from patients with scleroderma. J Biol Chem (1983) 1.98
Distribution of kinetochore (centromere) antigen in mammalian cell nuclei. J Cell Biol (1981) 1.97
Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence. Arthritis Rheum (1976) 1.92
Isolation and characterization of nuclear ribonucleoprotein complexes using human anti-nuclear ribonucleoprotein antibodies. J Biol Chem (1979) 1.92
Immunolocalization of 7-2-ribonucleoprotein in the granular component of the nucleolus. Exp Cell Res (1988) 1.87
Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest (1978) 1.86
Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med (1987) 1.84
Formation of assimilatory nitrate reductase by in vitro inter-cistronic complementation in Neurospora crassa. Proc Natl Acad Sci U S A (1970) 1.84
Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med (1984) 1.79
Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies. Clin Immunol (2001) 1.78
Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J Exp Med (1987) 1.76
Oral aspirin challenges in asthmatic patients: a study of plasma histamine. Clin Allergy (1976) 1.74
Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequences for RNA-binding. Nucleic Acids Res (1989) 1.72
Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res (1999) 1.68
Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung. Science (1979) 1.68
Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J Clin Invest (1993) 1.66
Epitopes, structural domains, and asymmetry of amino acid residues in SS-B/La nuclear protein. J Immunol (1986) 1.63
Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor. J Exp Med (1991) 1.63
Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest (1989) 1.61
Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen. J Clin Invest (1989) 1.59
Identification of ribosomal protein autoantigens. J Immunol (1985) 1.57
Fauna and geographical distribution of house dust mites in Korea. Korean J Parasitol (1997) 1.57
Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum (1988) 1.54
Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle. Exp Cell Res (1990) 1.53
High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum (1997) 1.53
Monoclonal anti-histone autoantibodies derived from murine models of lupus. J Immunol (1984) 1.52
Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med (1996) 1.52
IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. J Immunol (1986) 1.50
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol (2001) 1.49
Endoscopic management of colocutaneous fistula after percutaneous endoscopic gastrostomy. Endoscopy (2002) 1.49
Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity. J Immunol (1986) 1.49
Ultraviolet light alteration of cellular deoxyribonucleic acid in vivo. Proc Natl Acad Sci U S A (1969) 1.48
Autoantibodies and the spectrum of Sjögren's syndrome. Ann Intern Med (1979) 1.44
Studies on antibodies to histones by immunofluorescence. Scand J Immunol (1976) 1.43
Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ (1998) 1.43
Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol (2000) 1.43
Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity. J Exp Med (1984) 1.43
Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 1966. 96: 464-471. J Immunol (2006) 1.42
CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus. J Cell Biol (2000) 1.41
Coiled bodies in the nucleolus of breast cancer cells. J Cell Sci (1994) 1.41
Discovery of a novel member of the histamine receptor family. Mol Pharmacol (2001) 1.41
Microhemagglutination test for detection of antibodies to nuclear Sm and ribonucleoprotein antigens in systemic lupus erythematosus and related diseases. Am J Clin Pathol (1978) 1.40
In vitro posttranslational modification of lamin B cloned from a human T-cell line. Mol Cell Biol (1990) 1.40
Clinical profiles of bronchial asthma. JAMA (1973) 1.39
Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer (1993) 1.37
The development of clinical practice guidelines for treatment of peptic acid diseases in a VA ambulatory care clinic. Pharmacotherapy (1996) 1.37
Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol (2000) 1.36
An improved ELISA for anti-native DNA by elimination of interference by anti-histone antibodies. J Immunol Methods (1983) 1.36
Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest (1989) 1.36
Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum (1972) 1.35
The clinical significance of antinuclear antibodies. Postgrad Med (1973) 1.33
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33
Rat tracheal epithelial cells produce granulocyte/macrophage colony-stimulating factor. Am J Respir Cell Mol Biol (1990) 1.32
Recent progress in the study of autoantibodies to nuclear antigens. Hum Pathol (1978) 1.32
Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J Clin Invest (1981) 1.32